Major Interests in Shares

RNS Number : 1162O

Alliance Pharma PLC

02 March 2009

 



For Immediate Release

2 March 2009

Alliance Pharma

Notification of major interests in shares

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached

Alliance Pharma

2. Reason for the notification

An acquisition or disposal of voting rights

YES

3. Full name of person(s) subject to the notification obligation

RAB CAPITAL PLC ACTING AS DISCRETIONARY MANAGER OF RAB SPECIAL SITUATIONS (MASTER) FUND LIMITED

4. Full name of shareholder(s) (if different from 3.)

CREDIT SUISSE CLIENT NOMINEES (UK) LIMITED

5. Date of the transaction (and date on which the threshold is crossed or reached if different)

17/02/2009

6. Date on which issuer notified:

24/02/2009

7. Threshold(s) that is/are crossed or reached:

10%

8. Notified details:

n/a

A: Voting rights attached to shares

Class/type of shares if possible using the ISIN CODE

Situation previous to the Triggering transaction

Resulting situation after the triggering transaction

Number of Shares

Number of Voting Rights

Number of shares

Number of voting rights

% of voting rights

Direct

Direct

Indirect

Direct

Indirect

ORDINARY SHARES GB0031030819

17,818,399

10.99%

n/a

n/a

15,418,399

n/a

9.52%

B: Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Expiration date

Exercise/ Conversion Period/ Date

Number of voting rights that may be acquired if the instrument is exercised/ converted.

% of voting rights

n/a

n/a

n/a

n/a

n/a

Total (A+B)

Number of voting rights

% of voting rights

SEE ABOVE

9.52%

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable

RAB Capital Plc acts as investment manager for RAB SPECIAL SITUATIONS (MASTER) FUND LIMITED. RAB Capital plc does not act as custodian for its clients and therefore the shares are held in the nominee name of the custodian of its clients, which is CREDIT SUISSE CLIENT NOMINEES (UK) LIMITED.

Proxy Voting:

10. Name of the proxy holder:

n/a

11. Number of voting rights proxy holder will cease to hold:

n/a

12. Date on which proxy holder will cease to hold voting rights:

n/a

13. Additional information:

n/a

14. Contact name:

LEGAL TEAM

15. Contact telephone number:

020 7389 7000

ANNEX NOTIFICATION OF MAJOR INTERESTS IN SHARES

A: Identity of the person or legal entity subject to the notification obligation
Full name (including legal form for legal entities)	RAB CAPITAL PLC
Contact address (registered office for legal entities)	1 ADAM STREET, LONDON WC2N 6LE
Phone number	020 7389 7000
Other useful information (at least legal representative for legal persons)
B:     Identity of the notifier, if applicable
Full name	ALL AS ABOVE
Contact address
Phone number
Other useful information (e.g. functional relationship with the person or legal entity subject to the notification obligation)
C:    Additional information
n/a

  For further information: 

Alliance Pharma plc	+ 44 (0) 1249 466966
John Dawson, Chief Executive
Richard Wright, Finance Director
www.alliancepharma.co.uk
Buchanan Communications	+ 44 (0) 20 7466 5000
Mark Court / Rebecca Skye Dietrich
Numis Securities Limited	+ 44 (0) 20 7260 1000
Nominated Adviser: Michael Meade / Brent Nabbs
Corporate Broking: David Poutney

 

END

 

 

HOLILFILVIIFIIA